These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16732866)

  • 21. [Quantitative and functional characteristics of the T- and B-system of immunity in tuberculosis].
    Chernushenko EF; Kogosova LS; Petrashenko AI; Shaposhnik EN
    Probl Tuberk; 1978 Nov; (11):64-9. PubMed ID: 310119
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mechanisms of cellular immunity in rheumatic fever and rheumatoid diseases].
    Podwysocka-Harasimowicz M
    Wiad Lek; 1983 Aug; 36(15):1275-9. PubMed ID: 6359720
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay.
    Sostarich AM; Zolldann D; Haefner H; Luetticken R; Schulze-Roebecke R; Lemmen SW
    Infection; 2008 Feb; 36(1):31-5. PubMed ID: 18231721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
    Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
    J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of cefepime therapy in neutropenic patients with extended-spectrum beta-lactamase-producing Gram-negative bacteraemia.
    Wi YM; Kang CI; Cheong HS; Chung DR; Jung CW; Ko KS; Song JH; Peck KR
    Int J Antimicrob Agents; 2009 Apr; 33(4):384-6. PubMed ID: 19097866
    [No Abstract]   [Full Text] [Related]  

  • 26. Concomitant Staphylococcus aureus bacteriuria is associated with poor clinical outcome in adults with S. aureus bacteraemia.
    Huggan PJ; Murdoch DR; Gallagher K; Chambers ST
    J Hosp Infect; 2008 Aug; 69(4):345-9. PubMed ID: 18602184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
    Mave V; Garcia-Diaz J; Islam T; Hasbun R
    J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-course monotherapy strategy for treating bacteremia in the critically ill.
    Corona A; Wilson AP; Grassi M; Singer M
    Minerva Anestesiol; 2006 Oct; 72(10):841-57. PubMed ID: 17006421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New recommendations in the treatment of Gram-positive bacteraemia in dialysis patients.
    Ponticelli C
    Nephrol Dial Transplant; 2008 Jan; 23(1):27-32. PubMed ID: 17895260
    [No Abstract]   [Full Text] [Related]  

  • 31. [Abnormalities and changes in the T and B lymphocyte count and blood proteins in a patient with Klippel-Feil syndrome].
    Religa H; Klucznik R; Krupiński W
    Przegl Lek; 1982; 39(9):621-3. PubMed ID: 6983701
    [No Abstract]   [Full Text] [Related]  

  • 32. Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial.
    Broom J; Woods M; Allworth A; McCarthy J; Faoagali J; Macdonald S; Pithie A
    Scand J Infect Dis; 2008; 40(5):399-406. PubMed ID: 18418801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bacteremia in children with tumors or malignant diseases 1991-2000].
    Alfredsdóttir IH; Thors VS; Gudnason T; Jónmundsson G; Kristinsson JR; Jónsson OG; Kristinsson KG; Haraldsson A
    Laeknabladid; 2008 Jul; 94(7-8):531-9. PubMed ID: 18591728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How bacteraemia is reviewed by medicines licensing authorities in Europe.
    Toivonen M
    Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S103-7. PubMed ID: 17884354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis.
    Gaïni S; Pedersen SS; Koldkaer OG; Pedersen C; Moestrup SK; Møller HJ
    Clin Exp Immunol; 2008 Mar; 151(3):423-31. PubMed ID: 18190604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Timing and impact of infections in acute pancreatitis.
    Besselink MG; van Santvoort HC; Boermeester MA; Nieuwenhuijs VB; van Goor H; Dejong CH; Schaapherder AF; Gooszen HG;
    Br J Surg; 2009 Mar; 96(3):267-73. PubMed ID: 19125434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New recommendations in the treatment of Gram-positive bacteraemia in dialysis patients.
    Labriola L; Jadoul M
    Nephrol Dial Transplant; 2008 Jul; 23(7):2431-2; author reply 2432-3. PubMed ID: 18424462
    [No Abstract]   [Full Text] [Related]  

  • 38. Comment on: Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Blot S; Vandijck D; Vandewoude K; Depuydt P; Vogelaers D; Peleman R
    J Antimicrob Chemother; 2007 Dec; 60(6):1402. PubMed ID: 17913718
    [No Abstract]   [Full Text] [Related]  

  • 39. Daptomycin.
    Enoch DA; Bygott JM; Daly ML; Karas JA
    J Infect; 2007 Sep; 55(3):205-13. PubMed ID: 17629567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia.
    Kwon KT; Oh WS; Song JH; Chang HH; Jung SI; Kim SW; Ryu SY; Heo ST; Jung DS; Rhee JY; Shin SY; Ko KS; Peck KR; Lee NY
    J Antimicrob Chemother; 2007 Mar; 59(3):525-30. PubMed ID: 17213265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.